VOLITIONRX LTD — Form 8-K
Filed July 21, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
On July 17, 2026, VolitionRx Ltd. filed an 8-K reporting amendments to its articles of incorporation or bylaws (Item 5.03) and submission of matters to a vote of security holders (Item 5.07). The filing itself contains no substantive details of the specific amendments, dollar amounts, or voting results—only that these corporate governance actions occurred and related exhibits (certificate and XBRL data files) were filed.
Why this rating
Routine corporate governance filing. No material business, financial, or strategic change disclosed. Bylaws amendments and shareholder votes are common administrative events unrelated to operations.
Extracted items
- 5.03 charter/bylaw change
- 5.07 shareholder vote
- 9.01 exhibits
See more from July 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.